🇺🇸 FDA
Pipeline program

ACP-044 Dose A

ACP-044-005

Phase 2 small_molecule terminated

Quick answer

ACP-044 Dose A for Osteoarthritis Pain is a Phase 2 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ACADIA PHARMACEUTICALS INC
Indication
Osteoarthritis Pain
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials